Matthew Shea
Stock Analyst at Needham
(2.13)
# 2,914
Out of 5,156 analysts
4
Total ratings
66.67%
Success rate
7.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Shea
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TOI The Oncology Institute | Reiterates: Buy | $5 | $2.73 | +83.15% | 2 | Mar 9, 2026 | |
| EVH Evolent Health | Maintains: Buy | $15 → $4 | $3.04 | +31.58% | 1 | Feb 25, 2026 | |
| ASTH Astrana Health | Initiates: Buy | $28 | $24.72 | +13.27% | 1 | Dec 12, 2025 |
The Oncology Institute
Mar 9, 2026
Reiterates: Buy
Price Target: $5
Current: $2.73
Upside: +83.15%
Evolent Health
Feb 25, 2026
Maintains: Buy
Price Target: $15 → $4
Current: $3.04
Upside: +31.58%
Astrana Health
Dec 12, 2025
Initiates: Buy
Price Target: $28
Current: $24.72
Upside: +13.27%